NO20060400L - Sammensetninger for rensing og krystallisering av molekyler av interesse - Google Patents
Sammensetninger for rensing og krystallisering av molekyler av interesseInfo
- Publication number
- NO20060400L NO20060400L NO20060400A NO20060400A NO20060400L NO 20060400 L NO20060400 L NO 20060400L NO 20060400 A NO20060400 A NO 20060400A NO 20060400 A NO20060400 A NO 20060400A NO 20060400 L NO20060400 L NO 20060400L
- Authority
- NO
- Norway
- Prior art keywords
- crystallization
- interest
- compositions
- purification
- molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL15708603A IL157086A0 (en) | 2003-07-24 | 2003-07-24 | Multivalent ligand complexes |
| PCT/IL2004/000669 WO2005010141A2 (en) | 2003-07-24 | 2004-07-22 | Compositions for purifying and crystallizing molecules of interest |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060400L true NO20060400L (no) | 2006-03-27 |
Family
ID=32652285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060400A NO20060400L (no) | 2003-07-24 | 2006-01-25 | Sammensetninger for rensing og krystallisering av molekyler av interesse |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060121519A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1648995A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007515384A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060037337A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101415721A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2531492A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL157086A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06000944A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20060400L (cg-RX-API-DMAC7.html) |
| RU (1) | RU2006105648A (cg-RX-API-DMAC7.html) |
| SG (1) | SG145760A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005010141A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200600315B (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7956165B2 (en) | 2003-07-24 | 2011-06-07 | Affisink Biotechnology Ltd. | Compositions and methods for purifying and crystallizing molecules of interest |
| WO2006085321A2 (en) * | 2005-02-10 | 2006-08-17 | Affisink Biotechnology Ltd. | Compositions and methods for purifying and crystallizing molecules of interest |
| FR2902799B1 (fr) | 2006-06-27 | 2012-10-26 | Millipore Corp | Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide |
| US8163886B2 (en) * | 2006-12-21 | 2012-04-24 | Emd Millipore Corporation | Purification of proteins |
| US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
| US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
| WO2009064425A1 (en) * | 2007-11-13 | 2009-05-22 | Rational Affinity Devices, L.L.C. | Multistate affinity ligands for the separation and purification of antibodies, antibody fragments and conjugates of antibodies and antibody fragments |
| CA2708836A1 (en) * | 2007-12-17 | 2009-06-25 | Affisink Biotechnology Ltd. | Methods for purifying or depleting molecules or cells of interest |
| WO2009151514A1 (en) | 2008-06-11 | 2009-12-17 | Millipore Corporation | Stirred tank bioreactor |
| DK2370561T3 (da) | 2008-12-16 | 2019-10-21 | Emd Millipore Corp | Omrøringstankreaktor og fremgangsmåde |
| KR101855714B1 (ko) | 2010-03-05 | 2018-05-10 | 베링거 인겔하임 인터내셔날 게엠베하 | 항체의 선택적 농축 |
| CN102892791B (zh) | 2010-05-17 | 2017-05-17 | Emd密理博公司 | 用于纯化生物分子的刺激响应性聚合物 |
| US10030224B2 (en) | 2015-11-01 | 2018-07-24 | Ariel-University Research And Development Company Ltd. | Methods of analyzing cell membranes |
| WO2021152584A1 (en) | 2020-01-28 | 2021-08-05 | Ariel Scientific Innovations Ltd. | Methods of analyzing cell membranes |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4036945A (en) * | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
| US4331647A (en) * | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US5215927A (en) * | 1986-01-30 | 1993-06-01 | Fred Hutchinson Cancer Research Center | Method for immunoselection of cells using avidin and biotin |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US6740734B1 (en) * | 1994-01-14 | 2004-05-25 | Biovitrum Ab | Bacterial receptor structures |
| SE9400088D0 (sv) * | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| US6017719A (en) * | 1994-06-14 | 2000-01-25 | Nexell Therapeutics, Inc. | Positive and positive/negative cell selection mediated by peptide release |
| US20010008766A1 (en) * | 1998-03-17 | 2001-07-19 | Sylvia Daunert | Quantitative binding assays using green fluorescent protein as a label |
| US6589503B1 (en) * | 1998-06-20 | 2003-07-08 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US7198930B2 (en) * | 2000-02-29 | 2007-04-03 | Millennium Pharmaceuticals, Inc. | Human protein kinase, phosphatase, and protease family members and uses thereof |
| JP5398945B2 (ja) * | 2001-04-23 | 2014-01-29 | マリンクロッド エルエルシー | TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体 |
| US20040265921A1 (en) * | 2003-06-30 | 2004-12-30 | National University Of Singapore | Intein-mediated attachment of ligands to proteins for immobilization onto a support |
| US7956165B2 (en) * | 2003-07-24 | 2011-06-07 | Affisink Biotechnology Ltd. | Compositions and methods for purifying and crystallizing molecules of interest |
-
2003
- 2003-07-24 IL IL15708603A patent/IL157086A0/xx unknown
-
2004
- 2004-07-22 SG SG200806175-6A patent/SG145760A1/en unknown
- 2004-07-22 KR KR1020067000635A patent/KR20060037337A/ko not_active Withdrawn
- 2004-07-22 RU RU2006105648/13A patent/RU2006105648A/ru not_active Application Discontinuation
- 2004-07-22 EP EP04745009A patent/EP1648995A4/en not_active Withdrawn
- 2004-07-22 JP JP2006520982A patent/JP2007515384A/ja active Pending
- 2004-07-22 CA CA002531492A patent/CA2531492A1/en not_active Abandoned
- 2004-07-22 WO PCT/IL2004/000669 patent/WO2005010141A2/en not_active Ceased
- 2004-07-22 MX MXPA06000944A patent/MXPA06000944A/es not_active Application Discontinuation
- 2004-07-22 CN CNA2004800263533A patent/CN101415721A/zh active Pending
-
2006
- 2006-01-12 ZA ZA200600315A patent/ZA200600315B/xx unknown
- 2006-01-12 IL IL173107A patent/IL173107A0/en unknown
- 2006-01-12 US US11/330,112 patent/US20060121519A1/en not_active Abandoned
- 2006-01-25 NO NO20060400A patent/NO20060400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL157086A0 (en) | 2004-02-08 |
| US20060121519A1 (en) | 2006-06-08 |
| JP2007515384A (ja) | 2007-06-14 |
| KR20060037337A (ko) | 2006-05-03 |
| WO2005010141A3 (en) | 2009-03-26 |
| SG145760A1 (en) | 2008-09-29 |
| ZA200600315B (en) | 2007-04-25 |
| EP1648995A4 (en) | 2010-03-10 |
| CN101415721A (zh) | 2009-04-22 |
| IL173107A0 (en) | 2006-06-11 |
| RU2006105648A (ru) | 2006-07-27 |
| MXPA06000944A (es) | 2006-03-30 |
| EP1648995A2 (en) | 2006-04-26 |
| WO2005010141A2 (en) | 2005-02-03 |
| CA2531492A1 (en) | 2005-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cauz‐Santos | Beyond conservation: the landscape of chloroplast genome rearrangements in angiosperms | |
| Sosa et al. | Association between ancient bone preservation and DNA yield: a multidisciplinary approach | |
| Lee et al. | Complete chloroplast genomes of all six Hosta species occurring in Korea: molecular structures, comparative, and phylogenetic analyses | |
| MX2008010481A (es) | Compuestos que tienen afinado para el receptor f-ht6. | |
| BRPI0608376A8 (pt) | composição de ligação, método de uso de uma composição de ligação, e, kit de detecção | |
| ATE555202T1 (de) | Verfahren zur lieferung von rna-interferenz und verwendungen damit | |
| SG145760A1 (en) | Compositions for purifying and crystallizing molecules of interest | |
| WO2006069001A3 (en) | Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands | |
| ATE305035T1 (de) | Verfahren und verbindungen nützlich in der gezielten klonierung durch homologe rekombination | |
| TW200740761A (en) | Histone deacetylase inhibitors | |
| BRPI0514694A (pt) | produção de proteìna de fusão tnfr-ig | |
| BRPI0906104B8 (pt) | derivado de ácido peptonucleico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido peptonucleico, método de utilização do derivado de ácido peptonucleico e composto | |
| CA2369622A1 (en) | Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment | |
| WO2006122319A3 (en) | Histone deacetylase inhibitors | |
| BRPI0412813A (pt) | determinação da seqüência de um polinucleotìdeo | |
| WO2010011680A8 (en) | Discovery and utilization of sorghum genes (ma5/ma6) | |
| NO20021686D0 (no) | Fremgangsmåter for fremstilling av målemolekyler i et transgent dyr og rensing av målmolekylet | |
| WO2003074660A3 (en) | Modified chitin binding domain and uses thereof | |
| Kratena et al. | A unified approach to phytosiderophore natural products | |
| Gordiyenko et al. | Mass spectrometry defines the stoichiometry of ribosomal stalk complexes across the phylogenetic tree | |
| WO2006085321A3 (en) | Compositions and methods for purifying and crystallizing molecules of interest | |
| EP1801208A4 (en) | ANTI-A33 ANTIBODY | |
| Liao et al. | A novel polymeric silver (I) complex with a 2D brick structure | |
| Thomas et al. | Distamycin Analogues without Leading Amide at Their N‐Termini− Comparative Binding Properties to AT‐and GC‐Rich DNA Sequences | |
| Pandit et al. | A pmoA-based study reveals dominance of yet uncultured Type I methanotrophs in rhizospheres of an organically fertilized rice field in India |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |